Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Узловой зоб
Узловой зоб
Абдулхабирова Ф.М., Ванушко В.Э., Солдатова Т.В., Трошина Е.А. Узловой зоб. Методическое пособие. Consilium Medicum. 2019; 21 (12): 23–30. DOI: 10.26442/20751753.2019.12.190681
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В методическом пособии «Узловой зоб» отражены ключевые моменты эпидемиологии и патогенеза, современная концепция диагностики и дифференциальной диагностики различных морфологических вариантов узловых образований щитовидной железы. Продемонстрированы унифицированные классификации ультразвуковой и цитологической диагностики узлового зоба. Рассмотрены методы оптимизации радикального лечения. Методические рекомендации снабжены вспомогательным материалом, алгоритмом диагностики и ведения пациентов. Рекомендуется для эндокринологов, специалистов ультразвукового исследования, специалистов клинической лабораторной диагностики, радиологов, хирургов, врачей общей практики.
Ключевые слова: щитовидная железа, узловой зоб, узловой коллоидный зоб, рак щитовидной железы, ультразвуковое исследование, тонкоигольная аспирационная биопсия, классификация TIRADS, классификация Бетесда.
________________________________________________
The guidelines “Nodular goiter” present the key points of epidemiology and pathogenesis, modern diagnostic concept of diagnosis and differential diagnosis of various morphological variants of thyroid nodules. Standardized classifications of nodular goiter ultrasound and cytological diagnosis are demonstrated. Methods of radical treatment optimization are discussed. Guidelines are supplemented with supporting material and algorithm of diagnosis and treatment of these patients. Recommended for endocrinologists, ultrasound medical specialists, clinical laboratory medicine specialists, radiologists, surgeons, and general practitioners use.
Key words: thyroid gland, nodular goiter, nodular colloid goiter, thyroid cancer, ultrasound assessment, fine needle aspirate biopsy, TIRADS classification, Bethesda classification.
Полный текст
Список литературы
1. Трошина Е.А., Платонова Н.М,, Абдулхабирова Ф.М., Герасимов Г.А. Йододефицитные заболевания в Российской Федерации: время принятия решений. Под ред. И.И.Дедова, Г.А.Мельниченко. М.: Конти Принт, 2012.
[Troshina E.A., Platonova N.M,, Abdulkhabirova F.M., Gerasimov G.A. Iodine deficiency diseases in the Russian Federation: decision making time. Edited by I.I.Dedov, G.A.Mel'nichenko. Moscow: Konti Print, 2012 (in Russian).]
2. Трошина Е.А. Зоб. М.: МИА, 2012. [Troshina E.A. Goiter. Moscow: MIA, 2012 (in Russian).]
3. Ali ZS, Cibas ES. The Bethesda System For Reporting Thyroid Cytopathology –Springler. LLC 2010.
4. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria,
and Explanatory Springer International Publishing AG, 2018.
5. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Met Clin North Am 2001; 30: 361–400.
6. Haugen BR, Alexander EK, Bible KC et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (1): 1–147.
7. Cooper DS, Gerard DM, Haugen ВR, Kloos RT et al. The American Thyroid Association Guidelines Taskforce: R.Michael. Thyroid 2006; 16 (2): 1–33.
8. Kim EK. Thyroid imaging reporting and data system for US features ofnodules: a step in establishing better stratification ofcancer risk. Radiology 2011; 260: 892–9.
9. Park CS, Kim SH, Jung SL et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 2010; 38: 287–93.
10. Russ G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 2016; 35 (1): 25–38. https://doi.org/10.14366/usg.15027
11. Tessler FN, Middleton WD, Grant EG et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14. Issue 5: 587–95.
12. WHO, UNICEF and ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their elimination. Geneva: WHO, WHO/Euro/NUT, 2001.
2. Трошина Е.А. Зоб. М.: МИА, 2012. [Troshina E.A. Goiter. Moscow: MIA, 2012 (in Russian).]
3. Ali ZS, Cibas ES. The Bethesda System For Reporting Thyroid Cytopathology –Springler. LLC 2010.
4. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria,
and Explanatory Springer International Publishing AG, 2018.
5. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Met Clin North Am 2001; 30: 361–400.
6. Haugen BR, Alexander EK, Bible KC et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (1): 1–147.
7. Cooper DS, Gerard DM, Haugen ВR, Kloos RT et al. The American Thyroid Association Guidelines Taskforce: R.Michael. Thyroid 2006; 16 (2): 1–33.
8. Kim EK. Thyroid imaging reporting and data system for US features ofnodules: a step in establishing better stratification ofcancer risk. Radiology 2011; 260: 892–9.
9. Park CS, Kim SH, Jung SL et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 2010; 38: 287–93.
10. Russ G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 2016; 35 (1): 25–38. https://doi.org/10.14366/usg.15027
11. Tessler FN, Middleton WD, Grant EG et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14. Issue 5: 587–95.
12. WHO, UNICEF and ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their elimination. Geneva: WHO, WHO/Euro/NUT, 2001.
[Troshina E.A., Platonova N.M,, Abdulkhabirova F.M., Gerasimov G.A. Iodine deficiency diseases in the Russian Federation: decision making time. Edited by I.I.Dedov, G.A.Mel'nichenko. Moscow: Konti Print, 2012 (in Russian).]
2. Трошина Е.А. Зоб. М.: МИА, 2012. [Troshina E.A. Goiter. Moscow: MIA, 2012 (in Russian).]
3. Ali ZS, Cibas ES. The Bethesda System For Reporting Thyroid Cytopathology –Springler. LLC 2010.
4. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria,
and Explanatory Springer International Publishing AG, 2018.
5. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Met Clin North Am 2001; 30: 361–400.
6. Haugen BR, Alexander EK, Bible KC et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (1): 1–147.
7. Cooper DS, Gerard DM, Haugen ВR, Kloos RT et al. The American Thyroid Association Guidelines Taskforce: R.Michael. Thyroid 2006; 16 (2): 1–33.
8. Kim EK. Thyroid imaging reporting and data system for US features ofnodules: a step in establishing better stratification ofcancer risk. Radiology 2011; 260: 892–9.
9. Park CS, Kim SH, Jung SL et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 2010; 38: 287–93.
10. Russ G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 2016; 35 (1): 25–38. https://doi.org/10.14366/usg.15027
11. Tessler FN, Middleton WD, Grant EG et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14. Issue 5: 587–95.
12. WHO, UNICEF and ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their elimination. Geneva: WHO, WHO/Euro/NUT, 2001.
________________________________________________
2. Трошина Е.А. Зоб. М.: МИА, 2012. [Troshina E.A. Goiter. Moscow: MIA, 2012 (in Russian).]
3. Ali ZS, Cibas ES. The Bethesda System For Reporting Thyroid Cytopathology –Springler. LLC 2010.
4. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria,
and Explanatory Springer International Publishing AG, 2018.
5. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Met Clin North Am 2001; 30: 361–400.
6. Haugen BR, Alexander EK, Bible KC et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (1): 1–147.
7. Cooper DS, Gerard DM, Haugen ВR, Kloos RT et al. The American Thyroid Association Guidelines Taskforce: R.Michael. Thyroid 2006; 16 (2): 1–33.
8. Kim EK. Thyroid imaging reporting and data system for US features ofnodules: a step in establishing better stratification ofcancer risk. Radiology 2011; 260: 892–9.
9. Park CS, Kim SH, Jung SL et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 2010; 38: 287–93.
10. Russ G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 2016; 35 (1): 25–38. https://doi.org/10.14366/usg.15027
11. Tessler FN, Middleton WD, Grant EG et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14. Issue 5: 587–95.
12. WHO, UNICEF and ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their elimination. Geneva: WHO, WHO/Euro/NUT, 2001.
Авторы
Ф.М. Абдулхабирова*, В.Э. Ванушко, Т.В. Солдатова, Е.А. Трошина
ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, Москва, Россия
*a-fatima@yandex.ru________________________________________________
National Medical Research Center for Endocrinology, Moscow, Russia
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.